DL-96A Fully auto microbial identification and antimicrobial susceptibility testing system
Keywords:
Category:
Detailed description
- The DL-96A bacterial identification and antimicrobial susceptibility testing system builds on the strengths of the DL-96Ⅱ, offering an upgraded, fully automated platform that meets both domestic and international standards for bacterial and antimicrobial susceptibility testing.
- The operational workflow has been fully automated, reducing manual intervention and boosting efficiency, thereby enhancing both the timeliness of laboratory results and their accuracy. The statistical analysis capabilities have been refined, featuring in-hospital infection detection and analysis, with support for custom and multidimensional reporting, enabling flexible assessment of hospital antimicrobial use and bacterial infection patterns. In response to the increasingly serious issue of bacterial resistance, DL has introduced the DL120 testing card, expanding the range of susceptibility tests and offering a broader spectrum of drug‑concentration gradients. When used in conjunction with the DL‑96A bacterial identification and susceptibility testing system, this solution provides clinicians with an optimal microbiological testing strategy.
DL-compatible Reagent kit
[Bacterial Assay System Randomized In Vitro Diagnostic Reagent Plate (DL-120 Series Reagent Plates)]
(1) In vitro antimicrobial susceptibility testing not only meets the CLSI clinical breakpoint criteria and the CARSS surveillance requirements, but also satisfies the quality-control strain breakpoints.
(2) Compared with the DL-96 series reagent plates, the number of drug types has increased, including tigecycline, doxycycline, daptomycin, and others.
(3) Comparison with the DL-96 series reagent plates: the drug concentration gradients are increased, with typical gradient ranges of 5–7 steps.
DL-96 & DL-120 slats
[Bacterial Assay System Randomized In Vitro Diagnostic Reagent Plate (DL-96 Series Reagent Plate)]
(1) It can identify over 600 clinically common pathogenic microorganisms, including various members of the Enterobacteriaceae family, non-fermenting bacteria, staphylococci, streptococci, and yeasts.
(2) Available are standalone identification kits, antimicrobial susceptibility testing plates, and combined identification–susceptibility assay plates.
(3) In vitro antimicrobial susceptibility testing meets CLSI clinical breakpoints for the strain and satisfies CARSS surveillance requirements.
(DL-96E) Legend
(DL-120E) Legend
Recommended Products
Product Message
DL Biotech: Making infectious disease diagnosis faster and more accurate.
Are you ready to embark on a journey into the world of microbes?
DL Biotech WeChat Official Account
Tel: 0756-3391888
Zhuhai DL Biotech Co., Ltd.
Address: No. 59, Dingwan 10th Road, Jinwan District, Zhuhai City
Email: market@medicaldl.com
dl@medicaldl.com (for export business)
National After-Sales Customer Service Hotline: 400-9313-018
International Customer Service Hotline: +86 756 6292044
©2026 Zhuhai DL Biotech Co., Ltd.Website Development: China Enterprise Dynamics Zhuhai
SEO tags
Sorry, there is currently no content in this section.
You can view other sections.
Sorry, there is currently no content in the current column
You can check other sections
Business license
Business License